Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) in hepatitis C virus (HCV)-infected patients has a high risk of recurrence. Although eradication of HCV is expected to reduce this risk, the risk in patients with a history of HCC may be high after treatment with direct-acting antivirals (DAAs). AIM: To det...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Kazuto, Ito, Hiroyuki, Kawai, Kengo, Kashii, Yoshiro, Hayashi, Yuka, Murayama, Aiko, Minemura, Masami, Takahara, Terumi, Shimizu, Yukihiro, Yasuda, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258255/
https://www.ncbi.nlm.nih.gov/pubmed/35978673
http://dx.doi.org/10.4254/wjh.v14.i6.1190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258255/
https://www.ncbi.nlm.nih.gov/pubmed/35978673
http://dx.doi.org/10.4254/wjh.v14.i6.1190

Ejemplares similares